Borislav Dinov

Borislav Dinov

Auto-generated profile, based on publicly available information

Borislav Dinov

Department of Internal Medicine I, Cardiology and Angiology, Justus-Liebig-University Giessen , Giessen

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2014 in Circulation
Verified
Journal Article
Open access
PDF file
BDBorislav Dinov
Borislav Dinov
LFLukas Fiedler
Lukas Fiedler
RSRobert Schönbauer
Robert Schönbauer
ABAndreas Bollmann
Andreas Bollmann
SRSascha Rolf
Sascha Rolf
AAArash Arya
Arash Arya
Background—: Data on the outcomes of ventricular tachycardia (VT) ablation in nonischemic dilated cardiomyopathy (NIDCM) are insufficient. The Heart Center of Leipzig VT (HELP-VT) study was conducted prospectively to compare outcomes after radiofrequency catheter ablation of VT in patients with NIDCM compared with ischemic cardiomyopathy (ICM). Methods and Results—: Two hundred twenty-seven patients, 63 with NIDCM and 164 with ICM, presenting with sustained VT were ablated with radiofrequency catheter ablation. Noninducibility of any clinical and nonclinical VT was achieved in 66.7% of NIDCM and in 77.4% of ICM patients. Ablation of the clinical VT only was achieved in 18.3% of ICM and in 22.2% of NIDCM patients. There was no statistically significant difference in short-term outcomes between the 2 groups. At the 1-year follow-up, VT-free survival in NIDCM was 40.5% compared with 57% in ICM. In univariate analysis, the hazard ratio for VT recurrence was significantly higher for NIDCM (1.62; 95% confidence interval, 1.12– 2.34; P =0.01). In both the ICM and NIDCM subgroups, procedure failure and incomplete procedural success were independent predictors of VT recurrence. Conclusions—: Although the short-term success rates after VT ablation in NIDCM and ICM patients were similar, the long-term outcomes in NIDCM patients were significantly worse. Complete VT noninducibility at the end of the ablation is associated with beneficial long-term outcome in NIDCM. Pursuing compete elimination of all inducible VTs is desirable and may improve the long-term success in NIDCM.

1 November 2015 in Heart Rhythm
Verified
Journal Article
Closed access
JKJedrzej Kosiuk
Jedrzej Kosiuk
BDBorislav Dinov
Borislav Dinov
JKJelena Kornej
Jelena Kornej
WAWillem-Jan Acou
Willem-Jan Acou
RSRobert Schönbauer
Robert Schönbauer
SRSascha Rolf
Sascha Rolf

1 December 2014 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
BDBorislav Dinov
Borislav Dinov
AAArash Arya
Arash Arya
LBLivio Bertagnolli
Livio Bertagnolli
VSValentina Schirripa
Valentina Schirripa
KSKatharina Schoene
Katharina Schoene
GHGerhard Hindricks
Gerhard Hindricks
Background—: The effects of time to referral for catheter ablation (CA) of scar-related ventricular tachycardia (VT) on acute success, VT recurrence, and cardiac mortality are unclear. Methods and Results—: We investigated 300 patients after CA of sustained VT. CA was performed within 30 days after the first documented VT in 75 (25%) patients (group 1), between 1 month and 1 year in 84 (28%) patients (group 2), and >1 year after the first VT occurrence in 141 (47%) patients (group 3). The end points were noninducibility of any VT after CA (acute success), VT recurrence and cardiac mortality after 2 years. Acute success was achieved in 66 (88%) patients in group 1, 68 (81%) in group 2, and in 99 (70.2%) in group 3 ( P =0.008). During the 2-year follow-up period, VT recurred in 28 (37.3%) patients in group 1, 52 (61.9%) patients in group 2, and 91 (64.5%) patients in group 3 ( P <0.0001). Recurrence-free survival was higher in group 1, as compared with group 2 (hazard ratio [HR], 1.85; P =0.009) and group 3 (HR, 2.04; P =0.001). No survival difference was observed between groups 1 and 2 (HR, 0.85; P =0.68) and groups 1 and 3 (HR, 1.13; P =0.73). β-blocker therapy, VT of ischemic origin, and complete success were associated with VT-free survival. VT recurrence (HR, 1.91; P =0.037) predicted cardiac mortality. Conclusions—: CA of scar-related VT performed within 30 days after the first documented VT was associated with improved acute and long-term success. VT recurrence, but not the early referral for CA, was associated with cardiovascular mortality.

1 June 2015 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
PDF file
BDBorislav Dinov
Borislav Dinov
AAArash Arya
Arash Arya
ASAlexandra Schratter
Alexandra Schratter
VSValentina Schirripa
Valentina Schirripa
LFLukas Fiedler
Lukas Fiedler
GHGerhard Hindricks
Gerhard Hindricks
Background—: Data on outcomes after catheter ablation of ventricular tachycardia (VT) in patients with nonischemic dilated cardiomyopathy (NIDCM) are insufficient. We aimed to investigate the effects of successful catheter ablation of VT on cardiac mortality in patients with NIDCM. Methods and Results—: One hundred two patients with NIDCM (86 men; mean age, 58.8±15.2 years; mean ejection fraction, 33.3±11.9%) underwent VT ablation. After catheter ablation, a programmed ventricular stimulation to test for success was performed. Complete VT noninducibility was achieved in 62 (61%) patients and partial success or failure in 32 (31%) patients. During 2 years of follow-up, VT recurrence was observed in 33 patients (53%) without inducible VTs and in 24 patients (75%) with inducible VT inducible ( P =0.041). VT inducibility was associated with higher VT recurrence (adjusted hazard ratio, 1.84; 95% confidence interval, 1.08–3.13; P =0.025). The primary end point of all-cause mortality was reached in 9 patients (15%) with noninducible VTs versus 11 patients (34%) with inducible sustained VTs ( P =0.026). VT inducibility was associated with all-cause mortality (adjusted hazard ratio, 2.73; 95% confidence interval, 1.003–7.43; P =0.049). Conclusions—: In patients with NIDCM and recurrent sustained VTs, a complete ablation of all inducible VTs may be achieved in 60% of the cases. The complete noninducibility may be a preferable end point of ablation because it was associated with better long-term success. Importantly, if possible to achieve through ablation, a complete VT noninducibility was associated with reduction of the likelihood for all-cause mortality in patients with NIDCM.

1 December 2017 in Heart Rhythm
Verified
Journal Article
Closed access
EEElena Efimova
Elena Efimova
JFJulia Fischer
Julia Fischer
LBLivio Bertagnolli
Livio Bertagnolli
BDBorislav Dinov
Borislav Dinov
SKSimon Kircher
Simon Kircher
AAArash Arya
Arash Arya

1 June 2014 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
BDBorislav Dinov
Borislav Dinov
JKJedrzej Kosiuk
Jedrzej Kosiuk
SKSimon Kircher
Simon Kircher
ABAndreas Bollmann
Andreas Bollmann
WAWillem-Jan Acou
Willem-Jan Acou
SRSascha Rolf
Sascha Rolf
Background—: Recent studies reported worse outcomes after atrial fibrillation (AF) ablation in patients with metabolic syndrome (MetS). However, mechanisms of AF recurrence in MetS remain unclear. Method and Results—: We performed pulmonary vein isolation and voltage mapping in 236 patients with AF (age 61±9.6 years; persistent AF 64%; MetS 54%). Left atrial (LA) low voltage areas were semiquantitatively estimated and presented as low voltage index. MetS was defined according to National Cholesterol Education Program Adult Treatment Panel III. Follow-up for AF recurrence ≤12 months was performed. LA low voltage areas were observed in 46% of patients with MetS versus 8.2% patients without MetS ; P <0.0001. MetS was an independent predictor of LA low voltage areas: odds ratio, 11.64; 95% confidence interval, 4.381–30.903; P <0.0001. Observed AF recurrence at 12 months was 42.7% in MetS versus 36.1% in the non-MetS group ( P =0.303). The presence of LA low voltage areas was a predictor of 12-month AF recurrence: odds ratio, 2.99; 95% confidence interval, 1.36–6.56; P =0.006. Probability of 12-month AF recurrence increased with 84.5% for every unit of low voltage Index. Conclusions—: MetS was not associated with worse outcomes after radiofrequency catheter ablation of AF, but LA low voltage areas were more frequently observed in patients with MetS. The presence and extent of LA low voltage areas may influence the long-term outcomes after catheter ablation.